Kiley Juergens Wealth Management’s Gilead Sciences GILD Stock Holding History

Kiley Juergens Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$205K	Sell	1,620 -63	-4%	-$8.3K	0.03%	236
2026 Q1	$235K	Buy	+1,683	New	+$236K	0.04%	216
2018 Q4	–	Sell	-1,086	Closed	-$83K	–	266
2018 Q3	$83K	Buy	1,086 +785	+261%	+$59.3K	0.06%	173
2018 Q2	$21K	Buy	+301	New	+$21.3K	0.02%	319
2018 Q1	–	Sell	-301	Closed	-$21K	–	284
2017 Q4	$21K	Buy	+301	New	+$22.9K	0.02%	342

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kiley Juergens Wealth Management's GILD Position: Q2 2026 in Review

Kiley Juergens Wealth Management reduced its Gilead Sciences (GILD) stake by 3.7% in Q2 2026, selling an estimated $8.3K and leaving 1,620 shares worth $205K. The position accounts for 0.03% of the portfolio, ranked #236.

Kiley Juergens Wealth Management first reported a position in GILD in Q4 2017 and has held it in 5 quarters since. The position peaked at $235K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Kiley Juergens Wealth Management held 1,620 shares of Gilead Sciences worth $205K as of Q2 2026.
Kiley Juergens Wealth Management sold 63 Gilead Sciences shares in Q2 2026, an estimated $8.3K.
Gilead Sciences made up 0.03% of Kiley Juergens Wealth Management's portfolio in Q2 2026, its #236 holding.
Kiley Juergens Wealth Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 5 quarters since.
Kiley Juergens Wealth Management's Gilead Sciences position peaked at $235K in Q1 2026.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kiley Juergens Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.